Clinical Trial

Safety and Efficacy of Oral HX9428 Tablets in Subjects With Wet Age-related Macular Degeneration (wAMD)

Name: Safety and Efficacy of Oral HX9428 Tablets in Subjects With Wet Age-related Macular Degeneration (wAMD) — clinical trial record (NCT07185841)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This study will evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of Oral HX9428 tablets in patients with wet age-related macular degeneration(wAMD)

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-09-15.

Trial Details

NCT Number	NCT07185841
Lead Sponsor	Fujian Haixi Pharmaceuticals Co., Ltd.
Conditions	Wet Age-related Macular Degeneration (AMD)
Enrollment	198 participants
Start Date	2025-07-01
Primary Completion	2028-07-01 (estimated)
Study Completion	2029-01-07 (estimated)
Updated on ClinicalTrials.gov	2025-09-25